Moderna

Top jab makers lose combined $10bn of market value amid fears over growing public apathy

Vaccines also include original version of virus

US biotech claims rival Covid vaccine makers infringed patents underpinning jabs

New book details how talent, leaps of faith and dogged determination brought the pharma company to world attention in 2020

President hails ‘monumental step forward’ in battle against virus but parents have been more cautious in inoculating children

Interim results from its clinical trial showed the jab is safe and highly effective, company said

Interview: Horizon Therapeutics chief Tim Walbert sees Dublin at heart of its international expansion

With the virus rampant despite jabs, trials are underway to create intranasal vaccines

Pyongyang says it has kept its population Covid-free by sealing the country’s borders

Adoption of committee reports confirms extension intended to facilitate travel

Cantillon: Emerging markets surprise observers with vaccine preferences

Proxy advisers back shareholder resolutions as new shot shows promising results

Bosses of Pfizer, BioNTech and Moderna also see paper wealth grow as share prices surge

Ukraine’s president Zelenskiy makes cameo at scandal free ceremony after Oscars chaos

Request is significantly broader than Pfizer and its German partner BioNTech’s

‘We don’t need to push it in places we are not needed or wanted,’ says drugmaker’s VP

Three doses can protect against serious illness and death for a long time, studies suggest

European Medicines Agency says no evidence to suggest vaccines affect fertility

US mRNA pioneer in late stage discussions with government over move that would boost post-Brexit life sciences strategy

‘I was called an anti-vaxxer, and I took exception to that. My children are vaccinated’

Pharmaceutical manufacturer to focus on cancer and immunology

Increased infection and rush for boosters over season has reduced eligible population

Most are mild to moderate and many had resolved or were resolving when reported

Dr Barney Graham’s discovery was a key step in development of Covid-19 vaccines

Decreased demand after Christmas and high infection rate caused excess of supplies

Drug-maker to submit data to regulators worldwide given urgent need for boosters

Analysis: There are far bigger issues for Nphet to resolve around inoculation policy

Freemasons say they have been previously targeted by ‘ridiculous’ campaign

Early research suggests Omicron may cause milder illnesses than previous variants

Shareholder proposal demands pharma group open up Covid-19 vaccine tech to poorer countries

Who had a good year? Rachael Blackmore for one. Who didn’t? Stephen Donnelly, arguably

Net Results: From mRNA vaccines to discontent with Data Protection Commissioners

The data suggests those infected in UK are 40 per cent less likely to be hospitalised for a night or more

Just 13 per cent of people in Africa have received at least one dose of a Covid vaccine

The company made between 700m and 800m Covid-19 vaccine doses this year

Validity will be extended after booster shot without a time limit

Travel stocks fell 1 per cent, but were above their intra-day lows touched earlier in session

Staff work around the clock to get vaccines to every corner of the State

More than 1.46 million boosters administered to date with 250,000 receiving a jab this week

Surge in Omicron cases to see ‘even greater’ impact on ICU with numbers exceeding 200